Kawanishi, Japan

Kunio Takanohashi


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1982-1999

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kunio Takanohashi: Innovator in Vitamin Production

Introduction

Kunio Takanohashi is a prominent inventor based in Kawanishi, Japan. He has made significant contributions to the field of biochemistry, particularly in the production of essential vitamins. With a total of 8 patents to his name, Takanohashi has developed innovative methods that enhance the efficiency and yield of vitamin production.

Latest Patents

One of Takanohashi's latest patents is focused on the production of L-ascorbic acid. This method involves allowing an acid to act on 2-keto-L-gulonic acid in a mixture of an inert organic solvent and an aliphatic ketone, in the presence of water and a surfactant. This process achieves a high yield of 90% or more, making it an industrially advantageous method for producing L-ascorbic acid. Another significant patent is for a process that produces vitamin A derivatives. This process is particularly useful as it provides all-trans vitamin A derivatives in high yield and purity, which are valuable as medicaments, feed additives, and food additives.

Career Highlights

Takanohashi is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical and biotechnology sectors. His work has not only advanced the production techniques for vitamins but has also contributed to the overall efficiency of the industry.

Collaborations

Throughout his career, Takanohashi has collaborated with notable colleagues, including Mitsutaka Tanaka and Toru Yamano. These collaborations have fostered innovation and have led to the successful development of various patented processes.

Conclusion

Kunio Takanohashi's contributions to the field of vitamin production exemplify the impact of innovative thinking in biochemistry. His patents reflect a commitment to enhancing industrial processes, ultimately benefiting the pharmaceutical and food industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…